These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2179858)

  • 1. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine.
    Ward J
    Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatrics academy issues recommendations on use of Haemophilus influenzae type b conjugate vaccine.
    Clin Pharm; 1988 Sep; 7(9):634. PubMed ID: 3266482
    [No Abstract]   [Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
    Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
    Weinberg GA; Murphy TV; Granoff DM
    Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
    [No Abstract]   [Full Text] [Related]  

  • 6. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
    Wenger JD; Ward JI; Broome CV
    Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
    [No Abstract]   [Full Text] [Related]  

  • 8. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.
    Ward J; Brenneman G; Letson GW; Heyward WL
    N Engl J Med; 1990 Nov; 323(20):1393-401. PubMed ID: 2233906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland.
    Takala AK; Peltola H; Eskola J
    Laryngoscope; 1994 Jun; 104(6 Pt 1):731-5. PubMed ID: 8196448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 13. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.
    Weinberg GA; Granoff DM
    J Pediatr; 1988 Oct; 113(4):621-31. PubMed ID: 3050001
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia.
    Meekison W; Hutcheon M; Guasparini R; Arnott M; Scheifele D; Grace M; Humphreys G; Barreto L
    Can Dis Wkly Rep; 1989 Jul; 15(28):143-5. PubMed ID: 2791073
    [No Abstract]   [Full Text] [Related]  

  • 15. The 1990s: a decade of new vaccines.
    Murphy TV
    Pediatr Infect Dis J; 1991 Feb; 10(2):89-91. PubMed ID: 2062619
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemophilus influenzae type b vaccines: lessons for the future.
    Ward JI; Broome CV; Harrison LH; Shinefield H; Black S
    Pediatrics; 1988 Jun; 81(6):886-93. PubMed ID: 3259307
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
    Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 37(2):13-6. PubMed ID: 3122004
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
    Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b vaccine.
    Anderson P; Pichichero ME
    Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.